Stroke Recovery

Zhittya Genesis Medicine is pioneering an innovative treatment for stroke recovery through its Fibroblast Growth Factor 1 (FGF-1) therapy. Strokes often result from disrupted blood flow to the brain, leading to damaged neural networks and impaired cognitive or motor functions. FGF-1 is a powerful stimulator of angiogenesis—the formation of new blood vessels—and has demonstrated potential to restore blood flow and promote tissue repair in ischemic regions. By enhancing vascular regeneration, Zhittya aims to support the brain's natural healing process, potentially improving recovery outcomes for millions of stroke survivors worldwide. This groundbreaking approach addresses a critical need in stroke rehabilitation by targeting the underlying vascular damage.